September 27, 2007 -- The public relations office of AstraZeneca recently issued a statement saying that the company would outsource its drug manufacturing “where there is a sound business case.” Who could object to something as reasonable as that? But the statement was meant to sooth ruffled feathers after an AstraZeneca exec was quoted as saying that AstraZeneca would fully outsource all its drug manufacturing within ten years. More details...
